Addressing meibomian gland dysfunction and blepharitis in general is the key to suppressing the inflammatory nature of dry eye disease (DED). However, artificial tears (AT) still play a pivotal role in the management of the condition. The amount of eye drops available can make selection overwhelming for a doctor (let alone a patient). This lecture will help optometrists choose appropriate artificial drops based on the key properties. We will also simplify when it makes sense to turn to biological drops in the management of DED.

Almost 800 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• Thank you so much for a wonderfully informative presentation. The information was explained in a format I could understand very well.

• Dr. Madan really touched on topics that I needed new information about. Thank you.

• I learned a lot, excellent lecture, thank you

• Excellent presentations by both speakers!

• I appreciate all perspectives of managing Ocular Surface Disease.

Speakers: Dr. Mahnia Madan and Dr. Mark Eltis

Thank you to Thea for exhibiting at this event.

This event is COPE approved for 1 hour of CE credit.

COPE ID: 84179-TD

Category: Trt/Mngmnt Ocular Disease